Chan Barbara Y
Insider CIK 1676343 · AEGR VP, Chief Accounting Officer · NVLN See remarks
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NVLN NOVELION THERAPEUTICS INC. | F Tax w/h | 2019-09-24 | 2019-09-26 | 1,688 | $0.76 | $1.3K | 16,387 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | F Tax w/h | 2019-03-15 | 2019-03-19 | 996 | $1.26 | $1.3K | 18,075 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | F Tax w/h | 2018-12-06 | 2018-12-10 | 3,313 | $1.28 | $4.2K | 19,071 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | A Award deriv | 2018-08-22 | 2018-08-27 | 50,000 | — | $0 | 50,000 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | A Award deriv | 2018-03-15 | 2018-03-26 | 40,000 | — | $0 | 40,000 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | A Award | 2018-03-15 | 2018-03-26 | 8,600 | — | $0 | 22,384 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | F Tax w/h | 2017-12-06 | 2017-12-08 | 1,216 | $3.33 | $4.0K | 13,784 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | A Award deriv | 2017-05-01 | 2017-05-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | A Award deriv | 2016-12-06 | 2016-12-08 | 75,000 | — | $0 | 75,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | D To issuer deriv | 2016-11-29 | 2016-11-30 | 26,000 | — | $0 | 0 | SEC↗ |
| NVLN QLT INC/BC | A Award deriv | 2016-11-29 | 2016-12-01 | 26,665 | — | $0 | 26,665 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2016-07-01 | 2016-07-05 | 26,000 | — | $0 | 26,000 | SEC↗ |